+
in $
+103.77%
MSP Recovery, Inc.
in $
-37.24%
Cano Health, Inc.
in $
-2.13%
HMN FINANCIAL, INC.
LIFW CANO-WT HMNF
Price 3.24 0.01 27.99
Movement +$ 1.65 -$ 0.01 -$ 0.61
Market Cap. 22.4 M 19.3 M 125.0 M
Volume 29.1 M 32,459 156,666
Volume μ 1.3 M 0 8,884
EPS TTM -141.50 0.00 1.19
P/E TTM -0.02 0.00 23.52
Dividend Yield TTM -% -% -%
Shares Outstanding 6 M 2,121 M 4 M
Earnings Call Nov. 14, 2024 March 31, 2023 Oct. 17, 2024

Financial Comparison

Financial Statements
Click to show
LIFW
CANO-WT
HMNF
    • 2023
    • 2022
    • 2021
    • 2020
Profitability
Industry Average
Profit Margin
+95.67% YoY
-17.86
-0.32
-7.31
Gross Margin
+101.49% YoY
-1.41
0.91
-61.15
Operating Margin
+80.52% YoY
-24.98
-14.15
-72.66
EBT Margin
+84.17% YoY
-20.16
-17.16
-108.39
ETR
-% YoY
-
-
EPS
+52.53% YoY
-2.84
-3.00
-6.32
EPS Dil.
+52.53% YoY
-2.84
-3.00
-6.32
ROA
+87.64% YoY
-0.20
0.00
-0.02
ROE
+67.33% YoY
-0.27
-0.07
-0.21
ROIC
-816.88% YoY
-0.24
-0.36
-0.04
Takeaways
  • Negative 5Y revenue growth of --92.68% and +69.35% for the past 10 Years
  • The profit margin of -7.31 implies a positive signal, comparing the net margin against the industry avg. of -17.86
Market Prospects
P/E
-3,614.01% YoY
-7.24
-13.34
-0.36
P/B
-1,113.73% YoY
3.19
0.90
0.07
P/TB
-1,113.73% YoY
3.19
0.90
0.07
Earnings Yield
+97.31% YoY
-0.43
-0.07
-2.78
Other Metrics
EBITDA[in mil.]
+98.73% YoY
-
-1
-83
EBITDA Margin
+99.58% YoY
-22.81
-0.05
-10.79
WA[in mil.]
+72.26% YoY
-
2
8
WA Dil.[in mil.]
+72.26% YoY
-
2
8
Earnings & Forecasts
  • Hide e
    Reported
    Avg. Estimate
    Beat
    Miss
Next Earnings LIFW HMNF
Earnings Call Nov. 14, 2024 Oct. 17, 2024
Avg. EPS Forecast - -
Potential Delta 2 % %
Avg. Revenue Forecast - Mil. - Mil.
Potential Delta - % - %
Dividends

Investor Relations

Index
LIFW
Annual Statement n/a
Quarterly Statement n/a
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
Lobby Disclosure n/a
CANO-WT
Annual Statement March 15, 2023, midnight
Quarterly Statement Nov. 13, 2023, midnight
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
Lobby Disclosure n/a
HMNF
Annual Statement March 19, 2024, midnight
Quarterly Statement n/a
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
Lobby Disclosure n/a

Strategic Comparison

Risks & Opportunities

Yet not available for any. Try a different selection.